Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient

被引：17

作者：

Mercadal, L ^{[1
]}

Foltz, V ^{[1
]}

Isnard-Bagnis, C ^{[1
]}

Ourahma, S ^{[1
]}

Deray, G ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Dept Nephrol, F-75013 Paris, France

来源：

TRANSPLANTATION PROCEEDINGS | 2005年 / 37卷 / 10期

关键词：

D O I：

10.1016/j.transproceed.2005.11.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report the third case in the literature of a patient with a long-lasting renal allograft who experienced tuberculosis just after the switch from azathioprine to mycophenolate mofetil. The switch was likely responsible for the reactivation of dormant tuberculosis; prophylactic antituberculous treatment should be considered in cases of such a therapeutic change.

引用

页码：4241 / 4243

页数：3

共 23 条

[1] Hospitalizations for cytomegalovirus disease after renal transplantation in the United States
Abbott, KC
Hypolite, IO
Viola, R
Poropatich, RK
Hshieh, P
Cruess, D
Hawkes, CA
Agodoa, LY
[J]. ANNALS OF EPIDEMIOLOGY, 2002, 12 (06) : 402 - 409
[2] Graft-versus-host disease - Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients
Baudard, M
Vincent, A
Moreau, P
Kergueris, MF
Harousseau, JL
Milpied, N
[J]. BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 287 - 295
[3] Cho S, 1999, AM J KIDNEY DIS, V34, P296
[4] Corales R, 2000, Transpl Infect Dis, V2, P133, DOI 10.1034/j.1399-3062.2000.020306.x
[5] de Maar E F, 2002, Transpl Infect Dis, V4, P17, DOI 10.1034/j.1399-3062.2002.01002.x
[6] B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient
Ganschow, R
Lyons, M
Kemper, MJ
Burdelski, M
[J]. PEDIATRIC TRANSPLANTATION, 2001, 5 (01) : 60 - 63
[7] GRINYO J, 1995, LANCET, V345, P1321
[8] Mycophenolate mofetil in renal allograft recipients - A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
Halloran, P
Mathew, T
Tomlanovich, S
Groth, C
Hooftman, L
Barker, C
[J]. TRANSPLANTATION, 1997, 63 (01) : 39 - 47
[9] Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation
Hambach, L
Stadler, M
Dammann, E
Ganser, A
Hertenstein, B
[J]. BONE MARROW TRANSPLANTATION, 2002, 29 (11) : 903 - 906
[10] Laboratory assessment of immune function in renal transplant patients
Hutchinson, P
Chadban, SJ
Atkins, RC
Holdsworthl, SR
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) : 983 - 989

← 1 2 3 →